2015 Half-year report on Innate Pharma’s liquidity contract with Gilbert Dupont

July 2, 2015 at 7:31 AM CEST

Under the liquidity contract entrusted by Innate Pharma to Gilbert Dupont, the following assets appeared on the liquidity account as at June 30, 2015:

  • 26,811 shares of Innate Pharma, and
  • 334,840.22 euros in cash

As a reminder, at December 31, 2014, the following assets appeared on the liquidity account:

  • 33,310 shares of Innate Pharma, and
  • 233,366.36 euros in cash